Could a simple blood test curb antibiotic overuse in sick kids?

NCT ID NCT05350813

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether using a blood marker called procalcitonin (PCT) to guide antibiotic decisions can safely shorten treatment duration in children with bacterial infections in intensive care. About 296 children will be randomly assigned to either PCT-guided care or standard practice, and their total antibiotic use will be compared over 28 days. The goal is to see if this approach reduces unnecessary antibiotic exposure without compromising recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A procalcitonin (PCT)-guided algorithm to determine when to stop antibiotics, compared with standard care based on guidelines.
What this could lead to
If effective, this approach could reduce unnecessary antibiotic exposure in hospitalized children, lowering side effects and the risk of antibiotic resistance.
What could go wrong
The trial is relatively small and open-label, which may introduce bias. The algorithm may not be suitable for all infections, and there is a risk of undertreatment if it guides stopping antibiotics too early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHP

    ACTIVE_NOT_RECRUITING

    Paris, France

  • CHU Amiens Picardie

    ACTIVE_NOT_RECRUITING

    Amiens, France

  • CHU La Réunion

    RECRUITING

    Saint-Denis, France

  • CHU de Bordeaux

    ACTIVE_NOT_RECRUITING

    Bordeaux, France

  • CHU de Clermont Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • CHU de NANTES

    RECRUITING

    Nantes, France

  • University Hospital of Lille

    TERMINATED

    Lille, France

  • University Hospital of Toulouse

    RECRUITING

    Toulouse, 31100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.